An HFD induces dyslipidemia through multiple interrelated mechanisms, including the enhanced absorption of exogenous lipids, the stimulation of hepatic lipid synthesis, insulin resistance, reduced activity of lipolytic enzymes, and chronic inflammation. Here, INS is linked to metabolic syndrome.